
|Articles|September 1, 2004
Anti-angiogenic therapy explored for retinblastoma
Miami-Results from a preclinical tumor model indicate that anti-angiogenic therapy may offer a useful new approach for the treatment of retinoblastoma, said Timothy G. Murray, MD, at Angiogenesis 2004.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement




























